This is a standard Form 3 filing for a new insider. No trading signal or material corporate event is present. Monitor future Form 4 filings for any open-market purchases or sales by Laurie Keating.
Price Chart
Executive Summary
Laurie Keating filed a Form 3 initial statement of beneficial ownership with Kalaris Therapeutics, along with a Power of Attorney authorizing Andrew Oxtoby, Liisa Bayko, and Amy Vandekop to handle SEC filings on her behalf. This is a routine administrative filing required for new insiders and contains no financial data or trading activity. No material impact on the stock is expected.
Key Facts
- Laurie Keating filed a Form 3 initial statement of beneficial ownership with Kalaris Therapeutics.
- A Power of Attorney (Exhibit 24.1) was filed, appointing Andrew Oxtoby, Liisa Bayko, and Amy Vandekop as attorneys-in-fact for SEC filing purposes.
- The filing is dated for the period ending August 1, 2026, and was accepted on August 3, 2026.
- No beneficial ownership amounts, share counts, or transaction details are disclosed in the filing.
Financial Impact
No financial impact — the filing is a routine initial ownership statement with no disclosed holdings or transactions.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-330516 |
| Document: 0001193125-26-330516-index-headers.html | 0001193125-26-330516 |
| Document: 0001193125-26-330516-index.html | 0001193125-26-330516 |
| Document: 0001193125-26-330516.txt | 0001193125-26-330516 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | SC 13G | $1.80 | awaiting T+60 | — | $1.80 (−0.00%) |
Aug 11, 2026 10w ago | 8-K | $3.97 | awaiting T+60 | — | $1.80 (−54.66%) |
Aug 11, 2026 10w ago | Press Release | $3.97 | awaiting T+60 | — | $1.80 (−54.66%) |
Aug 3, 2026 12w ago | 3 | $4.32 | awaiting T+60 | — | $1.80 (−58.33%) |
Jul 20, 2026 14w ago | 8-K | $4.00 $2.23 | ▼ −44.25% | ▼ −49.09% | $1.80 (−55.00%) |
Jul 17, 2026 14w ago | 8-K | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.80 (−58.90%) |
Jul 17, 2026 14w ago | Press Release | $4.38 $2.26 | ▼ −48.40% | ▼ −53.09% | $1.80 (−58.90%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.36 $3.90 | ▼ −10.55% | ▼ −14.95% | $1.80 (−58.72%) |
May 12, 2026 23w ago | 8-K | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.80 (−62.42%) |
May 12, 2026 23w ago | Press Release | $4.79 $4.19 | ▼ −12.53% | ▼ −16.91% | $1.80 (−62.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers